PCRX · Company research
Pacira BioSciences, Inc. Common Stock (PCRX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 25.2 | $1,030,960,950 | 825085950.00 | 211.5833333333333333 | — | — | 5.3584527466358973 | 1.5342228740312154 | 18.3693419927303821 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.